Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth.
The global Hydroxycarbamide market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage Market Size & Forecast, Major Company of Product Type etc. :
Demand Coverage Market Size & Forecast, Consumer Distribution :
Sickle Cell Disease
Get More Information about this Report and TOC @ https://www.planetmarketreports.com/reports/global-hydroxycarbamide-market-10097
Company Coverage Sales data, Main Products & Services etc. :
Bristol Myers Squibb
Beijing Jialin Pharma
VHB Life Sciences
Major Region Market
Middle East & Africa